Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 5/2009

01-03-2009 | Case Report

Rheumatoid cranial pachymeningitis successfully treated with long-term corticosteroid

Authors: Yuichiro Ii, Shigeki Kuzuhara

Published in: Rheumatology International | Issue 5/2009

Login to get access

Abstract

We report a 68-year-old man without clinical history of rheumatoid arthritis who presented with acute bilateral palsy of the IX and X cranial nerves secondary to pachymeningitis confirmed on cranial MRI. Rheumatoid factor in both serum and cerebrospinal fluid and anti-agalactosyl IgG antibody in serum were positive. The radiographs of hands and feet revealed signs of early rheumatism. The dural biopsy specimen showed chronic inflammation with infiltration of lymphocytes and histiocytes. A diagnosis of rheumatoid cranial pachymeningitis was made. Treatment with long-term corticosteroid was excellently effective.
Literature
1.
2.
3.
4.
5.
Jackson CG, Chess RL, Ward JR (1984) A case of rheumatoid nodule formation within the central nervous system and review of the literature. J Rheumatol 11:237–240PubMed
6.
Markenson JA, McDougal JS, Tsairis P, Lockshin MD, Christian CL (1979) Rheumatoid meningitis: a localized immune process. Ann Intern Med 90:786–789PubMed
7.
Nishikawa M, Sakamoto H, Kishi H et al (1996) A case of rheumatoid factor-positive pachymeningitis. No To Shinkei 48:735–739 in Japanese with English abstractPubMed
8.
Ağildere AM, Tutar NU, Yücel E, Coşkun M, Benli S, Aydin P (1999) Pachymeningitis and optic neuritis in rheumatoid arthritis: MRI findings. Br J Radiol 72:404–407PubMed
Metadata
Title
Rheumatoid cranial pachymeningitis successfully treated with long-term corticosteroid
Authors
Yuichiro Ii
Shigeki Kuzuhara
Publication date
01-03-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0708-3

Other articles of this Issue 5/2009

Rheumatology International 5/2009 Go to the issue

Original Article

Association between the A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene and bone mineral density: a meta-analysis

Original Aricle

Impact of sex, age, body mass index and handedness on finger joint space width in patients with prolonged rheumatoid arthritis using computer-aided joint space analysis

Letter to the Editor

Serum and bronchoalveolar lavage fluid nitric oxide levels in diffuse systemic sclerosis

Case Report

Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy

Short Communication

Behçet’s disease: clinical value of the video capsule endoscopy for small intestine examination

Case Report

Coexistence of the monostatic Paget’s disease, sensorimotor neuropathy and elderly onset rheumatoid arthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits